FDA inspection
Natuzen Co., Ltd.: FDA inspection ending Nov 21, 2024
FDA inspection 1254945 · Voluntary Action Indicated (VAI) · Namdong District
Key facts
| Inspection ID | 1254945 |
|---|---|
| Firm | Natuzen Co., Ltd. |
| FEI number | 3006731547 |
| Address | 289 Namdongdong-Ro |
| City | Namdong District |
| Country | Korea (the Republic of) |
| Fiscal year | 2025 |
| Inspection end date | Nov 21, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data